136 related articles for article (PubMed ID: 37870147)
1. Naphthoyl benzhydrazine-decorated binuclear arene Ru(II) complexes as anticancer agents targeting human breast cancer cells.
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Grzegorz Małecki J
Dalton Trans; 2023 Nov; 52(44):16376-16387. PubMed ID: 37870147
[TBL] [Abstract][Full Text] [Related]
2. Exploring the cytotoxicity of dinuclear Ru(II)
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
[TBL] [Abstract][Full Text] [Related]
3. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
4. Promoting the Anticancer Activity with Multidentate Furan-2-Carboxamide Functionalized Aroyl Thiourea Chelation in Binuclear Half-Sandwich Ruthenium(II) Complexes.
Thangavel SK; Mohamed Kasim MS; Rengan R
Inorg Chem; 2024 Apr; 63(16):7520-7539. PubMed ID: 38590210
[TBL] [Abstract][Full Text] [Related]
5. Ru(II)-
Dorairaj DP; Haribabu J; Dharmasivam M; Malekshah RE; Mohamed Subarkhan MK; Echeverria C; Karvembu R
Inorg Chem; 2023 Jul; 62(30):11761-11774. PubMed ID: 37459067
[TBL] [Abstract][Full Text] [Related]
6. Studies on anticancer properties with varying co-ligands in a Ru(II) arene benzimidazole system.
Pragti ; Nayek S; Singh S; Sonawane A; Grabchev I; Ganguly R; Mukhopadhyay S
Dalton Trans; 2023 May; 52(21):7104-7118. PubMed ID: 37158792
[TBL] [Abstract][Full Text] [Related]
7. Half-sandwich Ru(η
Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
[TBL] [Abstract][Full Text] [Related]
8. On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).
Leite CM; de Araujo-Neto JH; Corrêa RS; Colina-Vegas L; Martínez-Otero D; Martins PR; Silva CG; Batista AA
Anticancer Agents Med Chem; 2021; 21(9):1172-1182. PubMed ID: 32838726
[TBL] [Abstract][Full Text] [Related]
9. New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity.
Iacopini D; Vančo J; Di Pietro S; Bordoni V; Zacchini S; Marchetti F; Dvořák Z; Malina T; Biancalana L; Trávníček Z; Di Bussolo V
Bioorg Chem; 2022 Sep; 126():105901. PubMed ID: 35671646
[TBL] [Abstract][Full Text] [Related]
10. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, Structure and Cytotoxicity of N,N and N,O-Coordinated Ru
Mukherjee A; Koley TS; Chakraborty A; Purkait K; Mukherjee A
Chem Asian J; 2021 Nov; 16(22):3729-3742. PubMed ID: 34549886
[TBL] [Abstract][Full Text] [Related]
12. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
13. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity.
Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707
[TBL] [Abstract][Full Text] [Related]
14. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, and Cytotoxicity of Morpholine-Containing Ruthenium(II)
Chatterjee R; Bhattacharya I; Roy S; Purkait K; Koley TS; Gupta A; Mukherjee A
Inorg Chem; 2021 Aug; 60(16):12172-12185. PubMed ID: 34346215
[TBL] [Abstract][Full Text] [Related]
16. Effective and Selective Ru(II)-Arene Complexes Containing 4,4'-Substituted 2,2' Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells.
Muralisankar M; Chen JR; Haribabu J; Ke SC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569273
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
18. Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.
Wang N; Ali A; Liu Z; Chi H; Lv Z; Zhao X; Zhang Z; Hao H; Zhang Y; Rahman FU
Eur J Med Chem; 2023 Oct; 258():115536. PubMed ID: 37295260
[TBL] [Abstract][Full Text] [Related]
19. Heterobimetallic Ru(ii)/Fe(ii) complexes as potent anticancer agents against breast cancer cells, inducing apoptosis through multiple targets.
Guedes APM; Mello-Andrade F; Pires WC; de Sousa MAM; da Silva PFF; de Camargo MS; Gemeiner H; Amauri MA; Gomes Cardoso C; de Melo Reis PR; Silveira-Lacerda EP; Batista AA
Metallomics; 2020 Apr; 12(4):547-561. PubMed ID: 32108850
[TBL] [Abstract][Full Text] [Related]
20. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
